Green Cross Cell Corp (031390):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Green Cross Cell Corp (031390) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10138
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Green Cross Cell Corp (Green Cross Cell), a subsidiary of Green Cross Corp, is a provider of immunotherapeutics for the treatment of cancer. The company offers Immuncell-LC, an anti-cancer immune therapeutic that is derived from lymphocytes of cancer patient. It offers cryopreservation of cord blood Cord blood that contains stem cells, which can be used to treat various diseases such as pediatric cancer, leukemia, stroke, diabetes, and liver diseases, among others. Green Cross Cell offers contract services ranging from manufacturing of the biopharmaceuticals, processing, cell storage, and consulting, to the product delivery. The company also carries out research programs targeted at the treatment of leukemia, pancreatic cancer, ovarian cancer, acquired immunodeficiency syndrome (AIDS) and glioblastoma. Green Cross Cell is headquartered in Seoul, South Korea.

Green Cross Cell Corp (031390) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Green Cross Cell Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Green Cross Cell Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Green Cross Cell Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Green Cross Cell Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Green Cross Cell Corp, Medical Devices Deals, 2012 to YTD 2018 9
Green Cross Cell Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Green Cross Cell Corp, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
AroCell Enters into Co-Development Agreement with Green Cross Cell 11
Green Cross Cell Forms Joint Venture with Harbin Hou pu Tong tang Biotech 12
Green Cross Cell and ToolGen to Enter into Partnership 13
Equity Offering 14
Innocell Completes Private Placement Of Shares For US$13 Million 14
Debt Offering 15
Green Cross Cell Raises USD55.3 Million in Private Placement of Convertible Bonds 15
Green Cross Cell Corp – Key Competitors 16
Green Cross Cell Corp – Key Employees 17
Green Cross Cell Corp – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Strategy And Business Planning 19
Sep 14, 2017: Green Cross Cell, Maryland agree to expand the cooperation between the biohealth and life science sectors 19
Legal and Regulatory 20
Aug 30, 2017: Green Cross Cell: Acquisition of INNO-BIZ certification 20
Product News 21
Apr 14, 2017: Green Cross Cell, the launch of a colorectal cancer clinical trial 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Green Cross Cell Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Green Cross Cell Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Green Cross Cell Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Green Cross Cell Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Green Cross Cell Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Green Cross Cell Corp, Medical Devices Deals, 2012 to YTD 2018 9
Green Cross Cell Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
AroCell Enters into Co-Development Agreement with Green Cross Cell 11
Green Cross Cell Forms Joint Venture with Harbin Hou pu Tong tang Biotech 12
Green Cross Cell and ToolGen to Enter into Partnership 13
Innocell Completes Private Placement Of Shares For US$13 Million 14
Green Cross Cell Raises USD55.3 Million in Private Placement of Convertible Bonds 15
Green Cross Cell Corp, Key Competitors 16
Green Cross Cell Corp, Key Employees 17

List of Figures
Green Cross Cell Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Green Cross Cell Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Green Cross Cell Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Green Cross Cell Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Green Cross Cell Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Green Cross Cell Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Green Cross Cell Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Green Cross Cell Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Green Cross Cell Corp, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Green Cross Cell Corp (031390):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Energy Fuels Inc (EFR):企業の財務・戦略的SWOT分析
    Energy Fuels Inc (EFR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Iridex Corp (IRIX)-医療機器分野:企業M&A・提携分析
    Summary Iridex Corp (IRIDEX) is a medical device company that manufactures and distributes laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology and otolaryngology market. The company provides products such as lasers, laser delivery devices, glaucoma devi …
  • Bonnier AB:企業の戦略的SWOT分析
    Bonnier AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Mustang Survival Corp.:企業の戦略・SWOT・財務情報
    Mustang Survival Corp. - Strategy, SWOT and Corporate Finance Report Summary Mustang Survival Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • HomeWorks Tri-County Electric Cooperative Inc:企業の戦略的SWOT分析
    HomeWorks Tri-County Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • CHC Group LLC:企業の戦略的SWOT分析
    CHC Group LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • The Bangchak Petroleum PCL (BCP):石油・ガス:M&Aディール及び事業提携情報
    Summary The Bangchak Petroleum PCL (Bangchak) is an oil and gas company. It carries out import of crude oil from both indigenous and overseas sources, and refines it into finished petroleum products. Its refinery produces gasoline, gasohol and diesel products. The company markets its petroleum produ …
  • Campbell Soup Company:企業の戦略・SWOT・財務分析
    Campbell Soup Company - Strategy, SWOT and Corporate Finance Report Summary Campbell Soup Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Canary Wharf Group Plc:企業の戦略・SWOT・財務情報
    Canary Wharf Group Plc - Strategy, SWOT and Corporate Finance Report Summary Canary Wharf Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • CaixaBank SA:企業の戦略・SWOT・財務情報
    CaixaBank SA - Strategy, SWOT and Corporate Finance Report Summary CaixaBank SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Relay Medical Corp (CHX):企業の財務・戦略的SWOT分析
    Summary Relay Medical Corp(Relay), formerly Chromedx Corp, is a medical technology company that develops medical devices for in vitro diagnostics and point-of-care testing. The company offers technologies based on granted and pending patents such as HemoPalm and AUF. Its HemoPalm provides a combinat …
  • Big Rivers Electric Corporation:企業の発電所・SWOT分析2018
    Big Rivers Electric Corporation - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on k …
  • Slovnaft AS (1SLN01AE):企業の財務・戦略的SWOT分析
    Slovnaft AS (1SLN01AE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Terramin Australia Ltd:企業の戦略・SWOT・財務分析
    Terramin Australia Ltd - Strategy, SWOT and Corporate Finance Report Summary Terramin Australia Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Amyris Inc (AMRS):企業の財務・戦略的SWOT分析
    Summary Amyris Inc (Amyris) formerly Amyris Biotechnologies Inc, is a healthcare product manufacturer that offers integrated renewable products. The company provides alternatives to a range of petroleum-sourced products and rare materials. It offers health and wellness products, clean beauty product …
  • ATLAS Oil Company:石油・ガス:M&Aディール及び事業提携情報
    Summary ATLAS Oil Company (ATLAS) is an oil and gas company that offers fuel supply and logistic services. The company’s services comprise supply, renewable fuels, bulk fueling, fuel on demand, logistics, fixed price contracts, frac site fueling, emergency refuel, crude hauling, transloading and on- …
  • Individual Restaurant Company Limited:企業の戦略・SWOT・財務分析
    Individual Restaurant Company Limited - Strategy, SWOT and Corporate Finance Report Summary Individual Restaurant Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Phu Hung Securities Company:企業の戦略的SWOT分析
    Phu Hung Securities Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Hindustan ZInc Ltd:戦略・SWOT・企業財務分析
    Hindustan ZInc Ltd - Strategy, SWOT and Corporate Finance Report Summary Hindustan ZInc Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Complexa Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Complexa Inc (Complexa) is a biopharmaceutical company that develops endogenous human cell signalling treatments for fibrosis and inflammation related diseases. The company’s lead product candidate products includes CXA-10 is an endogenous nitro fatty acid that modulates the human body’s mai …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆